Rhenovia Pharma Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rhenovia Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013230
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rhenovia Pharma Ltd (Rhenovia) is a biotechnology company that provides solutions for the treatment of Alzheimers disease and other central nervous system diseases. The company offers studies to academic research groups and industries based on biosimulation technology, which is a computational model to understand and study complex biological processes in disease research. It offers rheddos system, which is a drug discovery optimization service. Rhenovia offers case studies to healthcare companies. Rhenovia also offers first operational services towards drug candidates; and other consulting services. The company collaborates with the French Government. Rhenovia is headquartered in Mulhouse, France.

Rhenovia Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Rhenovia Pharma Raises US$0.7 Million In Series B Financing 10
Partnerships 11
Optivia Biotech Partners with Rhenovia Pharma 11
Rhenovia Pharma Enters Into Joint Venture With Portmann Instruments 12
Rhenovia Pharma Ltd – Key Competitors 13
Rhenovia Pharma Ltd – Key Employees 14
Rhenovia Pharma Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rhenovia Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Rhenovia Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rhenovia Pharma Raises US$0.7 Million In Series B Financing 10
Optivia Biotech Partners with Rhenovia Pharma 11
Rhenovia Pharma Enters Into Joint Venture With Portmann Instruments 12
Rhenovia Pharma Ltd, Key Competitors 13
Rhenovia Pharma Ltd, Key Employees 14

★海外企業調査レポート[Rhenovia Pharma Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • In’Tech Medical SAS:医療機器:M&Aディール及び事業提携情報
    Summary In'Tech Medical SAS (In'Tech Medical) is a medical device company that offers surgical equipment. The company designs, develops and manufactures orthopedic implants and instruments for the healthcare sector. Its surgical instruments include benders, calipers, cervical pin distractor, angled …
  • East Japan Railway Co:企業の戦略・SWOT・財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Daiwa Securities Group Inc:企業の戦略・SWOT・財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Amerisur Resources Plc (AMER):石油・ガス:M&Aディール及び事業提携情報
    Summary Amerisur Resources Plc (Amerisur) is an independent full cycle oil and gas company. It focuses on the exploration, development and production of oil and natural gas in onshore South America, primarily in Colombia and Paraguay. Amerisur has working interests in the Platanillo - OBA cluster, P …
  • Close Brothers Asset Management:企業の戦略・SWOT・財務情報
    Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Centrose LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrose LLC (Centrose) is a precision drug company that develops medicines to target diseased tissues. The company's product pipeline includes EDC1 (Dysadherin), EDC2 (CD147), EDC3 (CD98), EDC5 (CD44), and EDC8 (CD38). Its product EDC1 combines two proteins found in close proximity to treat …
  • VINCI Energies:電力:M&Aディール及び事業提携情報
    Summary VINCI Energies S.A. (Vinci), a subsidiary of Vinci SA, is a provider of energy efficiency and renewable energy solutions. The company offers heating, ventilation and air conditioning, electric power, mechanical engineering and information and communications technologies. Vinci operates in mu …
  • Lannett Company Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …
  • Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • The Madison Square Garden Co:企業の戦略・SWOT・財務情報
    The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report Summary The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • AcuFocus Inc-医療機器分野:企業M&A・提携分析
    Summary AcuFocus Inc (AcuFocus) is a medical device company that develops and markets technologies for the improvement of near vision. The company's products include kamra inlay, small aperture lens and acutarget HD instrument. It offers near vision solutions and develops ophthalmic medical devices. …
  • Women’s Choice Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that provides branded prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diab …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers active pharmaceutical ingredients and bulk drugs used in anti-neoplastics. It offers products …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆